Evidence Details for Cd4
PMID Title Journal Year Abstract
35178106 Therapeutic Effect of Catgut Implantation at Acupoint in a Mouse Model of Hepatocellular Carcinoma by Suppressing Immune Escape. Evid Based Complement Alternat Med. 2022 Feb 8;2022:5572869. doi: 10.1155/2022/5572869. eCollection 2022. 2022 BACKGROUND: The occurrence and development of hepatocellular carcinoma (HCC) are closely related to immune function, as is the capacity of hepatoma cells to escape. Immunosurveillance is a key mechanism. Catgut implantation at acupoint (CIAA) is a promising acupuncture improvement method that can regulate immunity and has been widely used in the clinical treatment of a variety of diseases. The aim of this study is to observe the therapeutic effect of CIAA on HCC and to investigate the potential mechanism of immune escape. MATERIALS AND METHODS: A total of 40 mice were randomly divided into three groups: the HCC model group (n = 15), the CIAA treatment group (n = 15), and the control group (n = 10). HCC was chemically induced in 30 mice by the combination of DEN, carbon tetrachloride, and ethanol for 150 days. Among them, 15 were selected for CIAA treatment to ascertain the therapeutic effect. The mRNA expression levels of AFP, IL-10, PD-1, and CTLA-4 in three groups were examined by using RT-PCR. AFP and AKT expressions were measured by using western blotting. PD1, CTLA-4, IL-10, CD4+, and CD8+ protein expression levels were evaluated by using IHC. The mortality rate, body weight, and psychological conditions of three groups were also compared. RESULTS: The mRNA and protein expression levels of AFP, PD-1, CTLA-4, and IL-10 were significantly downregulated in the CIAA-treated mice in comparison with HCC mice. IHC assay shows that CD4+ and CD8+ expression levels were notably upregulated after CIAA treatment. Western blotting assay shows that AKT pathway was deactivated in CIAA-treated mice. CIAA notably reduced the mortality rate and inhibited weight loss caused by HCC and improved the overall psychological condition of the mice. CONCLUSIONS: Taken together, our data corroborate the effective potency of CIAA in the treatment of HCC by and inhibiting immune escape and deactivating the AKT pathway."

Evidence Sentence: PD1, CTLA-4, IL-10, CD4+, and CD8+ protein expression levels were evaluated by using IHC.
Evidence Sentence: IHC assay shows that CD4+ and CD8+ expression levels were notably upregulated after CIAA treatment.
Evidence Sentence: The protein expression levels of CD4+, CD8+, IL-10, PD-1, and CTLA-4 were assessed using IHC.
Evidence Sentence: CD4+ was primarily expressed in the TILs cell membrane.
Evidence Sentence: No indication of CD4+ expression was found in the liver tissue of the control group.
Evidence Sentence: The expression of CD4+ in TILs was observed in the HCC group and the CIAA group, and the expression of CD4+ in the CIAA group was significantly higher than that in the HCC group.